Maze Therapeutics, Inc.

NASDAQ:MAZE

Biotechnology

Healthcare
$32.43 +0.74%

+$0.18 today

Market cap
$1.77B
Beta
2.26
P/E (TTM)
-11.0
EPS (TTM)
-$2.27
52W Low $9.83High $53.65

Volume 1.00M

Average 0.84M

Price history

Maze Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-8.83%

Period high

$51.84

Period low

$22.39

Latest

$32.43

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 9, 2026Nov 9, 2026
8-KNov 9, 2026Nov 9, 2026
4Nov 4, 2026Nov 4, 2026
4Oct 30, 2026Oct 30, 2026
8-KOct 16, 2026Oct 16, 2026
4Oct 2, 2026Oct 2, 2026
4Oct 2, 2026Oct 2, 2026
4Oct 1, 2026Oct 1, 2026
4Sep 8, 2026Sep 8, 2026
144Sep 4, 2026Sep 4, 2026
4Sep 4, 2026Sep 4, 2026
4Sep 4, 2026Sep 4, 2026
4Sep 4, 2026Sep 4, 2026
4Sep 4, 2026Sep 4, 2026
4Sep 3, 2026Sep 3, 2026

Competitors

Who does Maze Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about MAZE's filings, answered from its disclosures.

What is the latest MAZE filing?

The latest filing shown is 8-K dated Nov 9, 2026.

How many recent filings does MAZE have?

Intrinsic Alpha currently shows 20 recent filings for MAZE.